OrthAlign

Executive Summary

OrthAlign is a US-based medical device company founded in 2004, specializing in handheld, computer-assisted surgical technologies for orthopedic joint replacement procedures. Its flagship Lantern platform is designed to provide precise alignment in hip and knee arthroplasty, with a strong focus on the growing ambulatory surgery center (ASC) market. The company's mission is to make advanced surgical navigation accessible and cost-effective for any surgeon in any operating room, addressing the need for improved outcomes and efficiency in joint replacement surgery. OrthAlign operates in the competitive orthopedic navigation space, differentiating itself through a portable, user-friendly system that avoids the complexity and cost of traditional large-console navigation systems. OrthAlign is well-positioned to capitalize on the shift of joint replacement procedures to ASCs, driven by payer and patient demand for lower-cost, high-quality care. The Lantern platform's ease of use and affordability align with ASC requirements, potentially driving adoption. Key catalysts include potential FDA clearances for expanded indications, such as robotic-assisted capabilities or new joint applications, as well as clinical studies demonstrating improved outcomes. Strategic partnerships with implant manufacturers or hospital systems could also accelerate market penetration. With a strong value proposition and favorable market trends, OrthAlign presents a compelling opportunity in the medical device sector.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for Lantern platform with enhanced robotic-assisted features60% success
• Q1 2027Publication of pivotal clinical trial results demonstrating superior alignment accuracy and reduced complications70% success
• H2 2026Strategic partnership with a major orthopedic implant company for co-marketing or distribution50% success